Fast-Dissolving Sublingual Films of Terbutaline Sulfate: Formulation and In Vitro/In Vivo Evaluation

被引:37
作者
Sayed, Soha [1 ]
Ibrahim, Howida Kamal [2 ]
Mohamed, Magdy Ibrahim [2 ]
El-Milligi, Mohamed Farid [1 ]
机构
[1] Misr Univ Sci & Technol, Coll Pharm, Dept Pharmaceut, 6th Of October City, Egypt
[2] Cairo Univ, Fac Pharm, Dept Pharmaceut, Cairo 11562, Egypt
关键词
terbutaline sulfate; sublingual; fast dissolving film; OPTIMIZATION; INHALATION; DELIVERY;
D O I
10.1021/mp4000713
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Terbutaline sulfate fast dissolving sublingual films were prepared using seven drug compatible film formers in different combinations and proportions. The film polymers are maltodextrin, Na alginate, Carpabol 430, xanthan gum, HPMC E5, PVP K-25, and Na CMC. Propylene glycol and sorbitol were used as plasticizers and mannitol as filler. The optimum polymer concentrations and the plasticizer amount were selected on the basis of flexibility, tensile strength, and stickiness of the films. The prepared films were evaluated for their tensile strength, thickness uniformity, disintegration time (in vitro and in vivo), in vitro dissolution, and moisture content Polymer type rather than total polymer concentration or plasticizer amount showed a significant effect on the tested film properties. A randomized, single dose, crossover study was conducted in four healthy volunteers to compare the pharmacokinetic profile of terbutaline sulfate from the prepared films and the conventional oral tablets. The film formula of choice gave a significantly faster drug absorption rate and recorded a relative bioavailability of 204.08%. Sublingual films could be promising as a convenient delivery system for terbutaline sulfate in patients with swallowing problems. The improved extent of absorption (higher AUC((0-24))). indicates success in improving drug bioavailability, and the faster absorption rate could be promising for the management of acute episodes of asthma.
引用
收藏
页码:2942 / 2947
页数:6
相关论文
共 27 条
[1]   Relative bioavailability of terbutaline to the lung following inhalation, using urinary excretion [J].
Abdelrahim, Mohamed E. ;
Assi, Khaled H. ;
Chrystyn, Henry .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2011, 71 (04) :608-610
[2]  
Alagusundram M., 2009, International Journal of Pharmatech research, V1, P557
[3]  
Ali S., 2007, DRUG DEL TECHNOL, V7, P36, DOI [10.1016/S1773-2247(13)50068-2, DOI 10.1016/S1773-2247(13)50068-2]
[4]  
Arya A., 2010, INT J CHEMTECH RES, V2, P576
[5]  
Attama A. A., 2008, INDIAN J PHARM SCI, V70, P61
[6]   A METHOD FOR DETERMINATION OF THE ABSOLUTE PULMONARY BIOAVAILABILITY OF INHALED DRUGS - TERBUTALINE [J].
BORGSTROM, L ;
NILSSON, M .
PHARMACEUTICAL RESEARCH, 1990, 7 (10) :1068-1070
[7]  
David H., 1992, J PHARM SCI-US, V81, P1
[8]  
Davies D. S., 1984, EUR J RESP DIS S, V7, P134
[9]   Lung deposition and protective effect of terbutaline delivered from pressurized metered-dose inhalers and the turbuhaler in asthmatic individuals [J].
Derom, E ;
Borgström, L ;
Van Schoor, J ;
Löfroos, AB ;
Pauwels, R .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2001, 164 (08) :1398-1402
[10]   Formulation and evaluation of fast dissolving films for delivery of triclosan to the oral cavity [J].
Dinge, Aditya ;
Nagarsenker, Mangal .
AAPS PHARMSCITECH, 2008, 9 (02) :349-356